After receiving a doctorate in chemistry from Syracuse University, Anthony J. Di Pasqua, PhD, was a Ruth L. Kirschstein Postdoctoral Fellow in the Oncology Department at the Lombardi Comprehensive Cancer Center at Georgetown University, and a postdoctoral research associate and then research assistant professor in the Department of Molecular Pharmaceutics and the Center for Nanotechnology in Drug Delivery in the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Di Pasqua joined the University of North Texas System College of Pharmacy in November 2012, where he was involved with the development of the school, including all facets of the curriculum, admissions, procedures and policies, and faculty hiring.
He has expertise in teaching and directing Pharmaceutics 1 and 2 and nonsterile extemporaneous compounding. He is committed to teaching his students to think critically about science and how it applies to the practice of pharmacy.
Di Pasqua's research interests include nanomaterials for use in chemo- and radiotherapeutics and platinum-based anticancer agents. Work in his laboratory focuses on the development of novel delivery systems to enhance the efficacy of therapeutically active compounds while minimizing their side effects in patients and translating basic scientific concepts into therapeutic applications for use in the clinic.
In 2015, the American Association of Pharmaceutical Scientists (AAPS) highlighted Di Pasqua's Radiotherapeutic Bandage for the Treatment of Skin Cancer in a video interview and press release, which was made a EurekAlert! by the American Association for the Advancement of Science (AAAS).
Di Pasqua also serves as chair of the Basic Sciences section of the American Pharmacists Association (APhA).
- PhD, Syracuse University
- BS, Utica College of Syracuse University
- Chemo- and radio-therapeutics
- Platinum-based anticancer therapeutics
- recipient of the 2009 Syracuse University College of Arts and Sciences Doctoral Prize for thesis